This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Chemo-Sero-Therapeutic Research Institute, National Institute of Infectious Diseases, Tokushima University. Active years: 2015-2016.
Company Filing History:
2 out of 151 
1 out of 37 
1 out of 42 
Years Active: 2015-2016
Title: Tetsuhiro Harakawa: Innovator in Neurotoxin Research
Introduction
Tetsuhiro Harakawa is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of neurotoxin research, particularly in the development of novel therapeutic agents. With a total of 2 patents, his work focuses on improving the efficacy and safety of neuromuscular transmission blocking agents.
Latest Patents
Harakawa's latest patents include a novel type Atoxin preparation. This preparation serves as a neuromuscular transmission blocking agent, comprising a highly purified type Atoxin derived from the infant botulism pathogen. The medicament is designed to treat diseases characterized by muscle overactivity. Compared to conventional toxin preparations, this invention demonstrates rapid efficacy and a broader safety margin, making it suitable for therapeutic use in reducing local muscle overactivity.
Another significant patent involves a method for quantifying neurotoxin efficacy. This method allows for the quantitative measurement of the muscular relaxing activity of a neurotoxin. It includes a series of steps that involve administering the neurotoxin to a non-human mammal, applying electric stimulus, and measuring the compound muscle action potential (CMAP). This innovative approach offers high sensitivity, reproducibility, and accuracy in quantifying neurotoxin efficacy.
Career Highlights
Throughout his career, Harakawa has worked with esteemed institutions such as the Chemo-Sero-Therapeutic Research Institute and Tokushima University. His research has contributed to advancements in the understanding and application of neurotoxins in medical treatments.
Collaborations
Harakawa has collaborated with notable colleagues, including Sachio Okuda and Ryuji Kaji. These partnerships have further enriched his research and development efforts in the field of neurotoxin applications.
Conclusion
Tetsuhiro Harakawa's innovative work in neurotoxin research has led to significant advancements in therapeutic applications. His contributions continue to impact the medical field positively, showcasing the importance of innovation in addressing complex health issues.